As of 2026-06-09, the EV/EBITDA ratio of Sisram Medical Ltd (1696.HK) is 38.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1696.HK's latest enterprise value is 1,090.53 mil HKD. 1696.HK's TTM EBITDA according to its financial statements is 28.11 mil HKD. Dividing these 2 quantities gives us the above 1696.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 9.7x | 8.2x |
| Forward P/E multiples | 7.3x - 10.2x | 9.0x |
| Fair Price | 3.80 - 8.12 | 5.70 |
| Upside | 43.4% - 206.5% | 115.0% |
| Date | EV/EBITDA |
| 2026-06-05 | 4.95 |
| 2026-06-04 | 4.97 |
| 2026-06-03 | 5.02 |
| 2026-06-02 | 5.14 |
| 2026-06-01 | 5.10 |
| 2026-05-29 | 5.08 |
| 2026-05-28 | 5.14 |
| 2026-05-27 | 5.06 |
| 2026-05-26 | 5.23 |
| 2026-05-22 | 5.55 |
| 2026-05-21 | 5.38 |
| 2026-05-20 | 5.25 |
| 2026-05-19 | 5.27 |
| 2026-05-18 | 5.16 |
| 2026-05-15 | 5.27 |
| 2026-05-14 | 5.59 |
| 2026-05-13 | 5.48 |
| 2026-05-12 | 5.61 |
| 2026-05-11 | 5.59 |
| 2026-05-08 | 5.50 |
| 2026-05-07 | 5.63 |
| 2026-05-06 | 5.38 |
| 2026-05-05 | 5.46 |
| 2026-05-04 | 5.61 |
| 2026-04-30 | 5.53 |
| 2026-04-29 | 5.70 |
| 2026-04-28 | 5.74 |
| 2026-04-27 | 5.97 |
| 2026-04-24 | 5.76 |
| 2026-04-23 | 5.70 |
| 2026-04-22 | 5.89 |
| 2026-04-21 | 5.99 |
| 2026-04-20 | 6.04 |
| 2026-04-17 | 6.12 |
| 2026-04-16 | 5.93 |
| 2026-04-15 | 6.02 |
| 2026-04-14 | 6.25 |
| 2026-04-13 | 6.12 |
| 2026-04-10 | 6.19 |
| 2026-04-09 | 6.25 |
| 2026-04-08 | 6.48 |
| 2026-04-02 | 6.42 |
| 2026-04-01 | 6.46 |
| 2026-03-31 | 6.27 |
| 2026-03-30 | 6.38 |
| 2026-03-27 | 6.63 |
| 2026-03-26 | 6.46 |
| 2026-03-25 | 6.74 |
| 2026-03-24 | 6.72 |
| 2026-03-23 | 6.89 |